164 related articles for article (PubMed ID: 2481451)
1. Heterogeneity of human mast cells and basophils. Effects of a putative 5-lipoxygenase inhibitor.
Cohan V; McKenzie-White J; Triggiani M; Massey W; Kagey-Sobotka A; Lichtenstein LM
Biochem Pharmacol; 1989 Dec; 38(24):4455-9. PubMed ID: 2481451
[TBL] [Abstract][Full Text] [Related]
2. Effects of a specific inhibitor of the 5-lipoxygenase pathway on mediator release from human basophils and mast cells.
Warner JA; Lichtenstein LM; MacGlashan DW
J Pharmacol Exp Ther; 1988 Oct; 247(1):218-22. PubMed ID: 3139865
[TBL] [Abstract][Full Text] [Related]
3. The pharmacologic modulation of the release of arachidonic acid metabolites from purified human lung mast cells.
Peters SP; MacGlashan DW; Schleimer RP; Hayes EC; Adkinson NF; Lichtenstein LM
Am Rev Respir Dis; 1985 Aug; 132(2):367-73. PubMed ID: 3927806
[TBL] [Abstract][Full Text] [Related]
4. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor.
Ashida Y; Saijo T; Kuriki H; Makino H; Terao S; Maki Y
Prostaglandins; 1983 Dec; 26(6):955-72. PubMed ID: 6084855
[TBL] [Abstract][Full Text] [Related]
6. The role of 5-lipoxygenase pathway activation in basophil histamine release.
Morita Y; Suzuki S; Miyamoto T
Int Arch Allergy Appl Immunol; 1985; 78(1):77-80. PubMed ID: 2411671
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
Marone G; Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM
Agents Actions; 1986 Apr; 18(1-2):100-2. PubMed ID: 2425566
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
Triggiani M; Giannattasio G; Balestrieri B; Granata F; Gelb MH; de Paulis A; Marone G
Clin Exp Allergy; 2004 Feb; 34(2):241-9. PubMed ID: 14987304
[TBL] [Abstract][Full Text] [Related]
9. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
Marone G; Cirillo R; Genovese A; Marino O; Quattrin S
Life Sci; 1989; 45(19):1745-54. PubMed ID: 2480501
[TBL] [Abstract][Full Text] [Related]
10. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells.
Marone G; Columbo M; de Paulis A; Cirillo R; Giugliano R; Condorelli M
Agents Actions; 1986 Apr; 18(1-2):103-6. PubMed ID: 2425567
[TBL] [Abstract][Full Text] [Related]
11. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
12. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
13. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
Eggleston PA; Kagey-Sobotka A; Proud D; Adkinson NF; Lichtenstein LM
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
[TBL] [Abstract][Full Text] [Related]
14. Effects of the new 5-lipoxygenase inhibitor E6080 on leukotriene release in vitro.
Sakuma Y; Katayama S; Tsunoda H; Abe S; Yamatsu I; Katayama K
Int Arch Allergy Immunol; 1992; 97(4):267-73. PubMed ID: 1375926
[TBL] [Abstract][Full Text] [Related]
15. General anaesthetics induce only histamine release selectively from human mast cells.
Stellato C; Casolaro V; Ciccarelli A; Mastronardi P; Mazzarella B; Marone G
Br J Anaesth; 1991 Dec; 67(6):751-8. PubMed ID: 1722691
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.
Schulman ES; Post TJ; Henson PM; Giclas PC
J Clin Invest; 1988 Mar; 81(3):918-23. PubMed ID: 2449462
[TBL] [Abstract][Full Text] [Related]
17. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
Heavey DJ; Ernst PB; Stevens RL; Befus AD; Bienenstock J; Austen KF
J Immunol; 1988 Mar; 140(6):1953-7. PubMed ID: 2450136
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949.
Conroy MC; Kennedy JA; Chestnut JC; Wright CD; Adolphson RL; Thueson DO
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 1):902-8. PubMed ID: 1702129
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous effects of protamine on human mast cells and basophils.
Patella V; Ciccarelli A; Lamparter-Schummert B; de Paulis A; Adt M; Marone G
Br J Anaesth; 1997 Jun; 78(6):724-30. PubMed ID: 9215027
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs.
Marone G; Stellato C; Mastronardi P; Mazzarella B
Ann Fr Anesth Reanim; 1993; 12(2):116-25. PubMed ID: 7690200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
